Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study-Reference-Cited by-同舟云学术

Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study

Published:2021-09-17 Issue:1 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Klein Kim¹²^ORCID,Beverloo H. Berna³,Zimmermann Martin⁴,Raimondi Susana C.⁵,Neuhoff Christine⁶,Haas Valérie⁷²,Weelderen Romy¹²^ORCID,Cloos Jacqueline¹,Abrahamsson Jonas⁸,Bertrand Yves⁹,Dworzak Michael¹⁰,Fynn Alcira¹¹,Gibson Brenda¹²,Ha Shau‐Yin¹³,Harrison Christine J.¹⁴,Hasle Henrik¹⁵,Elitzur Sarah¹⁶,Leverger Guy¹⁷,Maschan Alexei¹⁸^ORCID,Razzouk Bassem¹⁹,Reinhardt Dirk⁶,Rizzari Carmelo²⁰,Smisek Pter²¹,Creutzig Ursula⁴,Kaspers Gertjan J. L.¹⁷²

Affiliation:

1. Pediatric Oncology, Cancer Center Amsterdam Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands

2. Department of Pediatric Hematology Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

3. Department of Clinical Genetics Erasmus MC University Medical Center Rotterdam The Netherlands

4. Pediatric Hematology/Oncology Hannover Medical School Hannover Germany

5. Department of Pathology St. Jude Children's Research Hospital Memphis Tennessee USA

6. Department of Pediatric Hematology‐Oncology University Hospital Essen Essen Germany

7. Clinical laboratory Dutch Childhood Oncology Group The Hague The Netherlands

8. Department of Pediatrics Queen Silvia Children's Hospital Gothenburg Sweden

9. Children's Leukemia Cooperative Group/European Organisation for Research and Treatment of Cancer Institut d'Hématologie et d'Oncologie Pédiatrique Lyon France

10. St. Anna Children's Hospital and Children's Cancer Research Institute Medical University of Vienna Vienna Austria

11. Grupo Argentino de Tratamiento de la Leucemia Aguda Children's Hospital La Plata La Plata Buenos Aires Argentina

12. Department of Paediatric Haematology United Kingdom Childhood Leukaemia Study Group Royal Hospital for Children Glasgow UK

13. Department of Pediatrics/Pediatric oncology Hong Kong Children's Hospital Hong Kong China

14. Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute Newcastle University Centre for Cancer Newcastle upon Tyne UK

15. Department of Pediatrics Aarhus University Hospital Skejby Aarhus Denmark

16. Schneider Children's Medical Center, Sackler School of Medicine Tel‐Aviv University Tel‐Aviv Israel

17. Hematopathology Department Assistance Publique Hopitaux de Paris Paris France

18. Oncology and Immunology Dmitriy Rogachev Federal Center for Pediatric Hematology Moscow Russia

19. Children's Center for Cancer and Blood Diseases Peyton Manning Children's Hospital at St. Vincent Indianapolis Indiana USA

20. Pediatric Hematology‐Oncology Unit, Department of Pediatrics University of Milano‐Bicocca, S. Gerardo Hospital Monza Italy

21. Department of Pediatric Hematology and Oncology Carles University in Prague/Second Faculty of Medicine and University Hospital Motol Prague Czech Republic

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29341

Reference38 articles.

1. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

2. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

3. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

4. Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98

5. Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Allogeneic Transplantation Favorably Influences the Outcome of Pediatric Acute Myeloid Leukemia—A Retrospective Study in a Single Center Over 2 Decades;Transplantation Proceedings;2024-01

2. Treatment results of children and adolescents with relapsed AML who were initially treated according to the AML-MM-2006 protocol;Russian journal of hematology and transfusiology;2023-07-17

3. TREATMENT RESULTS OF CHILDREN AND ADOLESCENTS WITH RELAPSED AML WHO WERE INITIALLY TREATED ACCORDING TO THE AML-MM-2006 PROTOCOL;GEMATOL TRANSFUZIOL;2023

4. Development and validation of a prognostic scoring model to risk stratify childhood acute myeloid leukaemia;British Journal of Haematology;2022-07-25

5. Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies;Leukemia;2022-06-06